We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+5.03%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$33.1B
AUM Growth
+$1.62B
(+5.1%)
Cap. Flow
+$885M
Cap. Flow
% of AUM
2.67%
Top 10 Holdings %
Top 10 Hldgs %
37%
Holding
1,568
New
69
Increased
691
Reduced
367
Closed
73
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$864M |
| 2 |
Bank of America
BAC
|
+$84.7M |
| 3 |
Edwards Lifesciences
EW
|
+$69M |
| 4 |
Alibaba
BABA
|
+$65.5M |
| 5 |
Advanced Micro Devices
AMD
|
+$56.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$83.9M |
| 2 |
Tyler Technologies
TYL
|
+$73.9M |
| 3 |
Core & Main
CNM
|
+$73M |
| 4 |
Itron
ITRI
|
+$71.3M |
| 5 |
Uber
UBER
|
+$70.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.91% |
| 2 | Healthcare | 15.81% |
| 3 | Financials | 12.06% |
| 4 | Communication Services | 11.11% |
| 5 | Consumer Discretionary | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Samsara
IOT
$23.9B
| $3.13M | 0.01% |
88,400
+8,000
| +10% | +$310K |
|
602
Wayfair
W
$13.8B
| $3.12M | 0.01% |
31,100
+100
| +0.3% | +$9.62K |
|
603
Camden Property Trust
CPT
$11.1B
| $3.09M | 0.01% |
28,100
| – | – |
|
604
Manhattan Associates
MANH
$11.8B
| $3.08M | 0.01% |
17,788
+2,500
| +16% | +$457K |
|
605
Repligen
RGEN
$9.47B
| $3.07M | 0.01% |
18,719
+827
| +5% | +$130K |
|
606
SharkNinja
SN
$26.6B
| $3.07M | 0.01% |
27,400
+6,900
| +34% | +$680K |
|
607
CF Industries
CF
$17.6B
| $3.06M | 0.01% |
39,600
-3,100
| -7% | -$255K |
|
608
Solventum
SOLV
$14.7B
| $3.06M | 0.01% |
38,600
-8,700
| -18% | -$666K |
|
609
Ascendis Pharma A/S
ASND
$16.2B
| $3.04M | 0.01% |
14,267
+700
| +5% | +$145K |
|
610
UDR
UDR
$12.2B
| $3.03M | 0.01% |
82,600
+800
| +1% | +$28.5K |
|
611
First Industrial Realty Trust
FR
$8.4B
| $3.02M | 0.01% |
52,774
-18,800
| -26% | -$1.05M |
|
612
Moderna
MRNA
$25.3B
| $3M | 0.01% |
101,800
-1,100
| -1% | -$29.9K |
|
613
Lamar Advertising Co
LAMR
$15.8B
| $3M | 0.01% |
23,681
| – | – |
|
614
Equity Lifestyle Properties
ELS
$12.6B
| $2.99M | 0.01% |
49,318
| – | – |
|
615
HP
HPQ
$28.3B
| $2.96M | 0.01% |
132,950
-205,104
| -61% | -$5.23M |
|
616
Lattice Semiconductor
LSCC
$18.3B
| $2.96M | 0.01% |
40,200
-2,300
| -5% | -$164K |
|
617
Madrigal Pharmaceuticals
MDGL
$11.7B
| $2.96M | 0.01% |
5,080
+680
| +15% | +$347K |
|
618
The Ensign Group
ENSG
$10.6B
| $2.94M | 0.01% |
16,867
+4,100
| +32% | +$737K |
|
|
RNAM
619
DELISTED
Avidity Biosciences
RNAM
| $2.94M | 0.01% |
40,700
+6,200
| +18% | +$400K |
|
620
Rambus
RMBS
$10.8B
| $2.92M | 0.01% |
31,797
-2,000
| -6% | -$197K |
|
621
Jefferies Financial Group
JEF
$12.9B
| $2.92M | 0.01% |
47,103
+5,800
| +14% | +$332K |
|
622
International Paper
IP
$21.8B
| $2.92M | 0.01% |
74,020
-58,562
| -44% | -$2.41M |
|
623
BridgeBio Pharma
BBIO
$15.8B
| $2.9M | 0.01% |
37,950
+3,300
| +10% | +$217K |
|
624
SPX Corp
SPXC
$10.6B
| $2.9M | 0.01% |
14,509
+2,900
| +25% | +$592K |
|
625
Cullen/Frost Bankers
CFR
$10.5B
| $2.86M | 0.01% |
22,616
+3,900
| +21% | +$489K |
|
Similar funds
VIA
GAM
Handelsbanken Fonder's Q4 2025 Portfolio in Review
As of Q4 2025, Handelsbanken Fonder held 1,568 positions worth $33.1B, up 5.1% from $31.5B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Handelsbanken Fonder's Q4 2025 filing shows 69 new, 691 increased, 367 reduced and 73 closed positions. Its largest new stake was Fluence Energy: 857,654 shares worth $17M. The largest sale was Eli Lilly, an estimated $83.9M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, down from 39% a quarter earlier, followed by Healthcare and Financials.
- Handelsbanken Fonder's largest Q4 2025 buy was Fluence Energy: 857,654 shares worth $17M.
- Handelsbanken Fonder added most to Amazon in Q4 2025, an estimated $864M increase.
- Handelsbanken Fonder's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $83.9M.
- Handelsbanken Fonder fully exited Kellanova in Q4 2025, selling an estimated $26M.
- Handelsbanken Fonder's ten largest holdings make up 37% of its $33.1B portfolio in Q4 2025.
- Handelsbanken Fonder opened 69 new positions and closed 73 in Q4 2025.
- Handelsbanken Fonder's portfolio value rose 5.1% quarter-over-quarter to $33.1B.
Based on Handelsbanken Fonder's 13F filing for Q4 2025, filed 6 Feb 2026.